Gene · 2767
Papers2,923
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
361 to 380 of 2,923
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Segmental vasoconstricted patches with a border of telangiectasia. | Pediatr Dermatol | 2023 | 37212738 | PubTator, text mining | PubMed |
| Plasma cell myeloma with RAS/BRAF mutations is frequently associated with a complex karyotype, advanced stage disease, and poorer prognosis. | Cancer Med | 2023 | 37212518 | PubTator, text mining | PubMed |
| New insights into the ambivalent role of YAP/TAZ in human cancers. | J Exp Clin Cancer Res | 2023 | 37211598 | PubTator, text mining | PubMed |
| Successful treatment of metastatic uveal melanoma with ipilimumab and nivolumab after severe progression under tebentafusp: a case report. | Front Oncol | 2023 | 37207136 | PubTator, text mining | PubMed |
| Genetic mutations in HER2-positive breast cancer: possible association with response to trastuzumab therapy. | Hum Genomics | 2023 | 37202799 | PubTator, text mining | PubMed |
| Need for a Dedicated Ophthalmic Malignancy Clinico-Biological Biobank: The Nice Ocular MAlignancy (NOMA) Biobank. | Cancers (Basel) | 2023 | 37190299 | PubTator, text mining | PubMed |
| FAK Inhibitor-Based Combinations with MEK or PKC Inhibitors Trigger Synergistic Antitumor Effects in Uveal Melanoma. | Cancers (Basel) | 2023 | 37190207 | PubTator, text mining | PubMed |
| Case Report: An NTRK1 fusion-positive embryonal rhabdomyosarcoma: clinical presentations, pathological characteristics and genotypic analyses. | Front Oncol | 2023 | 37188172 | PubTator, text mining | PubMed |
| Histological and Genetic Diversity in Ovarian Mucinous Carcinomas: A Pilot Study. | Curr Oncol | 2023 | 37185420 | PubTator, text mining | PubMed |
| Silent intrathyroid parathyroid carcinoma. | Endocrinol Diabetes Metab Case Rep | 2023 | 37183888 | PubTator, text mining | PubMed |
| DNA binding specificity of all four Saccharomyces cerevisiae forkhead transcription factors. | Nucleic Acids Res | 2023 | 37177995 | PubTator, text mining | PubMed |
| Incidence of Primary Hyperparathyroidism in the Current Era: Have We Finally Reached a Steady State? | J Clin Endocrinol Metab | 2023 | 37170854 | PubTator, text mining | PubMed |
| A case of large airway and orbital hemangiomas with facial capillary malformation. | Pediatr Dermatol | 2023 | 37164359 | PubTator, text mining | PubMed |
Clonal cytopenia of undetermined significance (CCUS)-associated reversion of donor-derived, transient αβ T-cell large granular clonal lymphocytosis, emerging post-transplant in a patient with a history of γδ T-cell large granular lymphocytic leukemia. | Cold Spring Harb Mol Case Stud | 2023 | 37160316 | PubTator, text mining | PubMed |
| Genomic profiling of a metastatic anaplastic melanocytic neuroectodermal tumor arising from a mature thymic teratoma as part of a mediastinal germ cell tumor. | Cold Spring Harb Mol Case Stud | 2023 | 37160315 | PubTator, text mining | PubMed |
| Structural insights into signal transduction of the purinergic receptors P2Y1R and P2Y12R. | Protein Cell | 2023 | 37155313 | PubTator, text mining | PubMed |
| Primary signet‑ring cell melanoma of the anorectum: A case report. | Oncol Lett | 2023 | 37153063 | PubTator, text mining | PubMed |
| PI3K/AKT/mTOR pathway-derived risk score exhibits correlation with immune infiltration in uveal melanoma patients. | Front Oncol | 2023 | 37152048 | PubTator, text mining | PubMed |
| Smaller panel, similar results: genomic profiling and molecularly informed therapy in pancreatic cancer. | ESMO Open | 2023 | 37148593 | PubTator, text mining | PubMed |
| Multiple epigenetic modification profiles reveal the tumor immune microenvironment and clinical outcomes of uveal melanoma. | Front Genet | 2023 | 37124608 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2767/papers?page=19